DT&CRO CO., Ltd.
Research DT&CRO CO., Ltd. (383930.KQ) on Bullrun: market cap KRW 29.98B. Explore financials, valuation history, model signals, and stock context.
Key Metrics
- Ticker383930.KQ
- ExchangeKQ
- CountrySouth Korea
- SectorHealthcare
- IndustryBiotechnology
- CurrencyKRW
- Market capKRW 29.98B
- Financial periodQ2 2026
- RevenueKRW 11.29B
- Net income-KRW 4.10B
- Free cash flow-KRW 1.74B
- Gross margin-4.5%
Valuation Snapshot
latest market cap is KRW 29.98B.
Valuation history
| Year | Snapshot date | Market cap | P/E | Dividend yield | Annual dividend/share |
|---|---|---|---|---|---|
| 2026 | 2026-10-18 | KRW 29.98B | n/a | n/a | n/a |
Dividend history
About DT&CRO CO., Ltd.
DT&CRO CO., Ltd. operates as a full-service CRO provider in South Korea. The company conducts a series of consigned studies ranging from non-clinical GLP toxicity, PK, and efficacy tests required for licensing of pharmaceuticals, chemicals, health functional food, cosmetics, and medical devices to analysis, bioactivity, clinical trials, and licensing consulting. DT&CRO CO., Ltd. was founded in 2017 and is based in Yongin-si, South Korea.
Related stock research
Other Healthcare stocks
Frequently asked questions
What is DT&CRO CO., Ltd.'s market cap?
DT&CRO CO., Ltd.'s market capitalization is KRW 29.98B.
What does DT&CRO CO., Ltd. do?
DT&CRO CO., Ltd. operates as a full-service CRO provider in South Korea. The company conducts a series of consigned studies ranging from non-clinical GLP toxicity, PK, and efficacy tests required for licensing of pharmaceuticals, chemicals, health functional food, cosmetics, and medical devices to analysis, bioactivity, clinical trials, and licensing consulting. DT&CRO CO., Ltd. was founded in 2017 and is based in Yongin-si, South Korea.